CureVac (NASDAQ:CVAC) Shares Purchased by Swiss National Bank

Swiss National Bank increased its position in shares of CureVac (NASDAQ:CVAC – Free Report) by 1.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 221,406 shares of the company’s stock after purchasing an additional 3,925 shares during the period. Swiss National […]

Leave a Reply

Your email address will not be published.

Previous post German American Bancorp, Inc. (NASDAQ:GABC) Shares Sold by Barclays PLC
Next post Swiss National Bank Increases Stake in Keros Therapeutics, Inc. (NASDAQ:KROS)